Bredt David's Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed Jan 16, 2026
- Accession no.
- 0001193125-26-015350
- Filed
- Jan 16, 2026
- Trade date
- Jan 15, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $228.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bredt DavidCIK 0002022087 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Common Stock | SSaleDisposed | −8,300 | $26.83 | −$222,689 | 395,775 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −200 | $27.40 | −$5,480 | 395,575 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.